GH Research PLC (GHRS) Quarterly EPS earnings growth

GH Research Corp - graphic logo of issuer GHRS

The quarterly EPS growth rate demonstrates the profitability dynamics of GH Research PLC (GHRS), where the value -51.80 expresses the metric level. The business focuses on psychiatric centers and individuals with severe depression. Growth is based on the implementation of inhaled GH001 for the rapid treatment of patients. However, success depends on the FDA verdict, and the absence of current sales creates serious investment risks.

GH Research (GHRS) - Year-over-year earnings per one share growth for the last 12 months from 07/04/2022 to 11/15/2026

Metric breakdowns and analytics for GH Research PLC (GHRS)

- share price and consensus valuation forecast:
Summary company analytics:GH Research Corp, GHRS
Flagship merchandise of GH Research Group

Investors are assessing the resilience of GH Research PLC (GHRS) through net profit dynamics. This indicator measures the percentage change in earnings per share per quarter, reflecting the efficiency of cost management. Analyzing the relative growth of quarterly EPS allows for tracking the impact of clinical successes in psychotherapy on profitability. The steady growth of the curve confirms the commercial value of the brand's scientific developments. However, purchasing the asset at the peak of the trend increases the risk of capital freeze.

Who GH Research PLC competes with

ALKS (alkermes.com) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Avadel Pharma (AVDL)|ATAI (atai.life) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Mind Medicine (MNMD)|Quarterly EPS earnings growth CMPS|LBRX (LB Pharmaceuticals, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months brightmindsbio.com DRUG|Vanda Pharmaceuticals (VNDA) - Earnings per share growth in annualized terms for the last twelve months|Cybin - Quarterly EPS earnings growth|ANRO - Quarterly EPS earnings growth|NRx Pharmaceuticals, Inc. (NRXP) - Year-over-year earnings per share growth for the last twelve months|CING - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Silo Pharma, Inc.|chinapharmaholdings.com (CPHI) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth CMND|Psyence Biomedical Ltd. - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months SciSparc Ltd SPRC|Seelos Therapeutics Inc. (SEEL) - Earnings per share growth in annualized terms for the last twelve months|VRPX: Year-over-year net earnings per share growth for the last 12 months|KRTX - Quarterly EPS earnings growth